Inflammation of adenohypophysis is commonly associated with headache in surgically managed Rathke’s cleft cysts

PituitaryPublished Retrospective case series

Authors' conclusion

Headache but not pituitary dysfunction was associated with adenohypophyseal inflammation. A trend of increasing headache prevalence was seen with increasing degree of inflammatory infiltrate within RCC.

Study context

Population
Patients with surgically managed Rathke's cleft cysts (RCC), April 2016–April 2024; median age 43 years (IQR 32–63), 77% female
Participants
31 patients
Exposure
Adenohypophysitis vs no adenohypophysitis in surgically managed RCC
  • Adenohypophysitisn = 12
Outcome
Headache
Follow-up
Preoperative
Methodological detailsindependent histopathology and radiology review
  • Independent histopathology and radiology review

Main finding

As reported in the abstract

P = 0.020

Headache present in all cases with chronic adenohypophyseal inflammation
11 cases

Observational data: associations, not effects.

Further findings

Inflammation of RCC (epithelium n = 13, cyst wall n = 20, adenohypophysis n = 12)

Inflamed RCC
23/31
Not inflamed
8 cases

Preoperative features

Pituitary dysfunction
70%
Headache
65%
Visual disturbance
26%
Polyuria/polydipsia
7%
Presented with features of apoplexy
6 patients

Pituitary dysfunction by inflammation overall

Pituitary dysfunction not associated with inflammation overall (76% vs. 70% p = ns)

Pituitary dysfunction by adenohypophysitis

Pituitary dysfunction not associated with adenohypophyseal inflammation (75 vs. 63% p = 0.69)

Radiological loss of posterior bright spot by histological inflammation

Histological inflammation associated with loss of posterior bright spot (70% vs. 14% p = 0.024)

Original publication

Inflammation of adenohypophysis is commonly associated with headache in surgically managed Rathke’s cleft cysts. Pituitary. Published 27 December 2024. doi:10.1007/s11102-024-01486-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.